Jorge S.
- Country
- Spain
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 1 of 16 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating acute myeloid leukemia (AML), with particular emphasis on developing therapeutic approaches for different patient populations.
- Relapsed/Refractory AML Treatment
- Novel Therapeutic Agents
- Treatment-Naive AML Management
Their research extends to both intensive and non-intensive treatment protocols for AML patients.
Targeted Therapies
The investigator focuses on evaluating novel targeted agents including tuspetinib and cusatuzumab for leukemia treatment.
- Kinase Inhibitor Studies
- Monoclonal Antibody Therapy
- Combination Treatment Approaches
Their work includes investigating innovative drug combinations with established therapies like azacitidine.
Personalized Medicine
The investigator develops treatment strategies for specific AML patient subgroups, particularly focusing on those who cannot receive intensive chemotherapy.
- Alternative Treatment Options
- Patient-Specific Approaches
- Treatment Optimization
Their research aims to expand therapeutic options for diverse AML patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.